Comprehensive Ophthalmological Evaluation in Atopic Dermatitis
Dermatology · 2024
DOI: 10.1159/000536233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology, 2024. Verfasst von Anaïs Valeille und 8 weiteren Autor:innen. Beteiligte Einrichtung: Allergy and Clinical Immunology Department, Lyon South University Hospital Center, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Introduction
Atopic dermatitis (AD), a chronic type 2 inflammatory skin disease, is frequently associated with ocular surface diseases (OSD) which may appear or worsen under anti-type 2-targeted treatments. However, the exact prevalence of OSD and the ophthalmology referral criteria remain ill-defined in AD patients before initiating such biotherapies. We aimed to characterize the prevalence, the nature and the factors related to OSD development in AD that may justify an ophthalmological management.
Methods
A total of 98 consecutive AD inpatients without biological treatment were retrospectively included. These were systematically evaluated by an ophthalmologist during their dermatological care. Clinical and laboratory data were analysed to characterize OSD and their risk factors.
Results
OSD were found in 83/98 AD patients (85%); mainly dry eye syndrome (64%, 63/98), allergic conjunctivitis (42%, 41/98), posterior (33%, 32/98), and anterior blepharitis (27%, 26/98). In AD patients without ocular symptoms, OSDs were also frequently found (63%, 12/19) and were mostly mild. Risk factors for OSD were history of allergic rhinitis, allergic sensitization, head and neck AD, ocular symptoms (foreign body sensation in the eye, burning, itching, photophobia), and total IgE level >3,000 kU/L.
Conclusion
The prevalence of OSD was high, even in asymptomatic patients. The risk factors identified may indicate the need for ophthalmological examination for therapeutic management, especially when biological agents targeting type 2 inflammation are considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Allergy and Clinical Immunology Department, Lyon South University Hospital Center, Hospices Civils de Lyon, Lyon, France.
- Immunology and Allergy Clinic, University Claude Bernard Lyon 1, Lyon, France.
- Ophthalmology Department, Lyon South University Hospital Center, Hospices Civils de Lyon, Lyon, France.
- Laboratoire de Biométrie et Biologie Évolutive, CNRS, University of Lyon, University Lyon 1, Villeurbanne, France.
- Biostatistics Department, Hospices Civils de Lyon, Lyon, France.
- CIRI (International Center for Infectiology Research) INSERM U1111, Lyon Higher Normal School, University Claude Bernard Lyon 1, Lyon, France.
Zitieren
APA
Valeille, A., Ouilhon, C., Subtil, F., Hacard, F., Jaulent, C., Bérard, F., Nicolas, J. F., Fauquert, J. L., & Nosbaum, A. (2024). Comprehensive Ophthalmological Evaluation in Atopic Dermatitis. Dermatology. https://doi.org/10.1159/000536233
Vancouver
Valeille A, Ouilhon C, Subtil F, Hacard F, Jaulent C, Bérard F, et al. Comprehensive Ophthalmological Evaluation in Atopic Dermatitis. Dermatology. 2024. doi:10.1159/000536233
BibTeX
@article{Valeille2024,
author = {Valeille, Anaïs and Ouilhon, Coralie and Subtil, Fabien and Hacard, Florence and Jaulent, Coline and Bérard, Fréderic and Nicolas, Jean-François and Fauquert, Jean-Luc and Nosbaum, Audrey},
title = {Comprehensive Ophthalmological Evaluation in Atopic Dermatitis},
journal = {Dermatology},
year = {2024},
doi = {10.1159/000536233}
}
EUVIMED